NanoVibronix, Inc. announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (RCT) study of UroShield.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.721 USD | -5.34% | -2.04% | -37.30% |
1st Jan change | Capi. | |
---|---|---|
-37.30% | 2.12M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- NAOV Stock
- News NanoVibronix, Inc.
- NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan